Search research articles
Contact Us
Filters
Showing results (191-200 of 200) with videos related to
Page
of 20
Sort By:
You have reached the last page of results.
This site can display upto 200 results.
The New England Journal of Medicine
|
June 23, 2006
Cyclophosphamide versus placebo in scleroderma lung disease
Donald P Tashkin, Robert Elashoff, Philip J Clements, et al.
The New England Journal of Medicine
|
March 18, 2011
Efficacy and safety of sirolimus in lymphangioleiomyomatosis
Francis X McCormack, Yoshikazu Inoue, Joel Moss, et al.
Arthritis and Rheumatism
|
May 1, 2007
Impact of oral cyclophosphamide on health-related quality of life in patients with active scleroderma lung disease: results from the scleroderma lung study
Dinesh Khanna, Xiaohong Yan, Donald P Tashkin, et al.
The European Respiratory Journal
|
September 18, 2025
Two randomised controlled phase 2 studies of the oral neutrophil elastase inhibitor alvelestat in alpha-1 antitrypsin deficiency
J Michael Wells, Ingrid L Titlestad, Hanan Tanash, et al.
Annals of the American Thoracic Society
|
March 11, 2025
Longitudinal Outcomes in Pi*MZ Alpha-1 Antitrypsin Deficient Individuals with Tobacco Smoking History from the SPIROMICS Cohort
Igor Barjaktarevic, Roxana Hixson, Zian Zhuang, et al.
American Journal of Respiratory and Critical Care Medicine
|
August 25, 2007
Effects of 1-year treatment with cyclophosphamide on outcomes at 2 years in scleroderma lung disease
Donald P Tashkin, Robert Elashoff, Philip J Clements, et al.
American Journal of Respiratory and Critical Care Medicine
|
March 24, 2025
The Use of CT Densitometry for the Assessment of Emphysema in Clinical Trials: A Position Paper from the Fleischner Society
Raúl San José Estépar, R Graham Barr, Sean B Fain, et al.
American Journal of Respiratory and Critical Care Medicine
|
September 16, 2016
Official American Thoracic Society/Japanese Respiratory Society Clinical Practice Guidelines: Lymphangioleiomyomatosis Diagnosis and Management
Francis X McCormack, Nishant Gupta, Geraldine R Finlay, et al.
The Lancet. Respiratory Medicine
|
July 30, 2016
Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trial
Donald P Tashkin, Michael D Roth, Philip J Clements, et al.
European Respiratory Review : an Official Journal of the European Respiratory Society
|
October 6, 2020
Updated guidance on the management of COVID-19: from an American Thoracic Society/European Respiratory Society coordinated International Task Force (29 July 2020)
Chunxue Bai, Sanjay H Chotirmall, Jordi Rello, et al.
Page
of 20
Search research articles
Search
Showing results (191-200 of 200) with videos related to
Sort By:
Page
of 20
You have reached the last page of results.
This site can display upto 200 results.
The New England Journal of Medicine
|
June 23, 2006
Cyclophosphamide versus placebo in scleroderma lung disease
Donald P Tashkin, Robert Elashoff, Philip J Clements, et al.
The New England Journal of Medicine
|
March 18, 2011
Efficacy and safety of sirolimus in lymphangioleiomyomatosis
Francis X McCormack, Yoshikazu Inoue, Joel Moss, et al.
Arthritis and Rheumatism
|
May 1, 2007
Impact of oral cyclophosphamide on health-related quality of life in patients with active scleroderma lung disease: results from the scleroderma lung study
Dinesh Khanna, Xiaohong Yan, Donald P Tashkin, et al.
The European Respiratory Journal
|
September 18, 2025
Two randomised controlled phase 2 studies of the oral neutrophil elastase inhibitor alvelestat in alpha-1 antitrypsin deficiency
J Michael Wells, Ingrid L Titlestad, Hanan Tanash, et al.
Annals of the American Thoracic Society
|
March 11, 2025
Longitudinal Outcomes in Pi*MZ Alpha-1 Antitrypsin Deficient Individuals with Tobacco Smoking History from the SPIROMICS Cohort
Igor Barjaktarevic, Roxana Hixson, Zian Zhuang, et al.
American Journal of Respiratory and Critical Care Medicine
|
August 25, 2007
Effects of 1-year treatment with cyclophosphamide on outcomes at 2 years in scleroderma lung disease
Donald P Tashkin, Robert Elashoff, Philip J Clements, et al.
American Journal of Respiratory and Critical Care Medicine
|
March 24, 2025
The Use of CT Densitometry for the Assessment of Emphysema in Clinical Trials: A Position Paper from the Fleischner Society
Raúl San José Estépar, R Graham Barr, Sean B Fain, et al.
American Journal of Respiratory and Critical Care Medicine
|
September 16, 2016
Official American Thoracic Society/Japanese Respiratory Society Clinical Practice Guidelines: Lymphangioleiomyomatosis Diagnosis and Management
Francis X McCormack, Nishant Gupta, Geraldine R Finlay, et al.
The Lancet. Respiratory Medicine
|
July 30, 2016
Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trial
Donald P Tashkin, Michael D Roth, Philip J Clements, et al.
European Respiratory Review : an Official Journal of the European Respiratory Society
|
October 6, 2020
Updated guidance on the management of COVID-19: from an American Thoracic Society/European Respiratory Society coordinated International Task Force (29 July 2020)
Chunxue Bai, Sanjay H Chotirmall, Jordi Rello, et al.
Page
of 20